Correction: Safety and efficacy of nemolizumab for patients with pruritus: a systematic review and meta-regression analysis of randomized controlled trial
Junqin Liang, Fengxia Hu, Maoli Dan, Yingbing Sang, Kailibinuer Abulikemu, Qian Wang, Yongzhen Hong, Xiaojing Kang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDermatology and Skin Diseases · Psoriasis: Treatment and Pathogenesis · Urticaria and Related Conditions
The title of this article was erroneously given as: “Safety and Efficacy of Nemolizumab for Atopic Dermatitis with Pruritus: A systematic review and meta-regression analysis of randomized controlled trial”. The correct title of the article is “Safety and efficacy of nemolizumab for patients with pruritus: a systematic review and meta-regression analysis of randomized controlled trial”.
There was a mistake in Table 1 as published. There was no ClinicalTrial.com.cn registration number provided, and the description of the study population was incomplete. The corrected Table 1 appears below.
There was a mistake in Table 2 as published. We omitted a subgroup analysis for patients with AD only; this has now been added to the second row after ‘Pruritus VAS”.
The corrected Table 2 appears below.
There were few textual/grammatical errors throughout the article as given below:
In the Abstract; the phrase “in treating patients with AD” has been corrected to: “in treating patients with pruritus”
In Section “1. Introduction Section, Paragraph Number: 3”; “pruritus” was incorrectly written as “AD”. The phrase now reads: “pruritus by assessing the amelioration of pruritus”.
In Section “2. Materials and Methods Section, 2.1 “Literature search” Sub-section, Paragraph Number: 1”; “and”, has been corrected to “or”. The phrase now reads: “atopic dermatitis or pruritus”.
In Section “Results Section, 3.2 “Characteristics of the studies”, Paragraph Number: 1”; there was a lack of the explanation of the two no-AD studies. This has been added now and it reads: “Two of the included studies did not involve AD patients, one focused on individuals with prurigo nodularis (Ständer, S., et al., 2020), and the other on hemodialysis (Kinugasa, E., 2021).”
The original version of this article has been updated.